MoneyWorks4Me

Kilitch Drugs(India) - Quaterly Results

11 Aug 2023 Evaluate
The sales moved up 32.06% to Rs. 311.25 millions for the June 2023 quarter as compared to Rs. 235.69 millions during the year-ago period.A good growth in profit of 38.95% reported to Rs. 41.88  millions over Rs. 30.14 millions of corresponding previous quarter.Operating Profit saw a handsome growth to 62.17 millions from 45.19 millions in the quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 311.25 235.69 32.06 311.25 235.69 32.06 1177.84 1051.60 12.00
Other Income 9.78 13.92 -29.74 9.78 13.92 -29.74 45.98 45.59 0.86
PBIDT 62.17 45.19 37.57 62.17 45.19 37.57 217.71 155.54 39.97
Interest 3.79 0.73 419.18 3.79 0.73 419.18 9.85 6.63 48.57
PBDT 58.38 44.46 31.31 58.38 44.46 31.31 207.86 148.91 39.59
Depreciation 2.57 2.72 -5.51 2.57 2.72 -5.51 13.37 9.64 38.69
PBT 55.81 41.74 33.71 55.81 41.74 33.71 194.49 139.27 39.65
TAX 13.93 11.60 20.09 13.93 11.60 20.09 37.31 34.01 9.70
Deferred Tax -5.93 -1.20 394.17 -5.93 -1.20 394.17 -4.66 -2.33 100.00
PAT 41.88 30.14 38.95 41.88 30.14 38.95 157.18 105.26 49.33
Equity 155.82 155.82 0.00 155.82 155.82 0.00 155.82 155.82 0.00
PBIDTM(%) 19.97 19.17 4.18 19.97 19.17 4.18 18.48 14.79 24.97
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..